Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alphamed is a leading healthcare solutions provider based in the United Arab Emirates and a core division of the Al Khayyat Investments (AKI) conglomerate. Established in 1982, the company has grown into one of the region's most significant distributors of pharmaceuticals, medical equipment, and diagnostic technologies. Alphamed represents a diverse portfolio of global healthcare leaders, including Roche, MSD, and Gilead, facilitating their market entry and expansion within the UAE. The company's operations are organized into specialized units that provide comprehensive services ranging from regulatory affairs and marketing to sophisticated supply chain logistics. By partnering with international innovators, Alphamed ensures that advanced medical treatments and state-of-the-art hospital equipment are accessible to healthcare providers and patients across the Middle East.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alphamed Group.